BREXPIPRAZOLE

BREXPIPRAZOLE was reported 16890 times

BREXPIPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCHIZOAFFECTIVE DISORDER 206 0.1154
1 COLLAGEN-VASCULAR DISEASE 8 0.1143
2 SINUS RHYTHM 45 0.1034
3 AKATHISIA 880 0.0644
4 MANIC SYMPTOM 9 0.0536
5 SPASMODIC DYSPHONIA 16 0.0528
6 METASTATIC CARCINOID TUMOUR 5 0.0481
7 DISCOLOURED VOMIT 46 0.0479
8 ACTIVATION SYNDROME 14 0.0405
9 OCULOGYRIC CRISIS 81 0.0377
10 LACTATION DISORDER 18 0.0370
11 SOCIAL ANXIETY DISORDER 24 0.0365
12 INABILITY TO AFFORD MEDICATION 360 0.0362
13 DELUSION OF REFERENCE 5 0.0360
14 PATIENT ELOPEMENT 13 0.0355
15 TONGUE MOVEMENT DISTURBANCE 29 0.0339
16 GAMBLING DISORDER 81 0.0300
17 COMPULSIVE SHOPPING 60 0.0291
18 GAMBLING 33 0.0283
19 HALLUCINATION, TACTILE 17 0.0255
20 PROLACTIN-PRODUCING PITUITARY TUMOUR 5 0.0254
21 PARAKERATOSIS 8 0.0247
22 TARDIVE DYSKINESIA 603 0.0214
23 BINGE EATING 23 0.0213
24 COMPULSIONS 14 0.0210
25 COGWHEEL RIGIDITY 21 0.0200
26 SOLILOQUY 16 0.0185
27 ABULIA 17 0.0184
28 REDUCED FACIAL EXPRESSION 18 0.0177
29 DROPPED HEAD SYNDROME 7 0.0177
30 REGRESSIVE BEHAVIOUR 5 0.0172
31 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 121 0.0169
32 DRUG-GENETIC INTERACTION 6 0.0168
33 PERSONAL RELATIONSHIP ISSUE 11 0.0164
34 PERSECUTORY DELUSION 41 0.0164
35 COMPULSIVE HOARDING 5 0.0156
36 PSYCHOTIC SYMPTOM 32 0.0155
37 ORTHOSTATIC HYPERTENSION 9 0.0154
38 PARKINSONISM 149 0.0153
39 MARASMUS 23 0.0151
40 BLOOD PROLACTIN ABNORMAL 13 0.0151
41 HALLUCINATION, AUDITORY 238 0.0150
42 COMPULSIVE SEXUAL BEHAVIOUR 12 0.0148
43 BLOOD PROLACTIN INCREASED 69 0.0146
44 HYPOMANIA 52 0.0141
45 HYPERSEXUALITY 25 0.0137
46 DRUG DOSE TITRATION NOT PERFORMED 25 0.0136
47 FEELING GUILTY 18 0.0136
48 INTRUSIVE THOUGHTS 16 0.0136
49 INSURANCE ISSUE 202 0.0132
50 AUTOSCOPY 7 0.0130
51 HYPERPHAGIA 51 0.0128
52 SCHIZOPHRENIA 153 0.0126
53 PERSISTENT DEPRESSIVE DISORDER 5 0.0124
54 FLAT AFFECT 28 0.0121
55 RESPIRATORY TRACT INFECTION BACTERIAL 6 0.0120
56 MANIA 197 0.0120
57 DRUG LEVEL INCREASED 190 0.0115
58 DIVORCED 5 0.0113
59 ANTIDEPRESSANT DRUG LEVEL INCREASED 4 0.0113
60 DRUG TITRATION ERROR 29 0.0112
61 BLUNTED AFFECT 8 0.0108
62 EMOTIONAL POVERTY 19 0.0108
63 TORTICOLLIS 22 0.0104
64 SUICIDAL BEHAVIOUR 43 0.0103
65 TRICHOTILLOMANIA 6 0.0102
66 SEDATION COMPLICATION 26 0.0102
67 DISTRIBUTIVE SHOCK 23 0.0101
68 BRUXISM 54 0.0100
69 NEUROPSYCHOLOGICAL SYMPTOMS 6 0.0100
70 FOOD CRAVING 52 0.0099
71 BORDERLINE PERSONALITY DISORDER 7 0.0099
72 RESTLESSNESS 360 0.0098
73 PSYCHIATRIC DECOMPENSATION 19 0.0097
74 PARKINSONIAN GAIT 6 0.0096
75 SELF-DESTRUCTIVE BEHAVIOUR 8 0.0092
76 IMPULSIVE BEHAVIOUR 34 0.0091
77 NEUROLEPTIC MALIGNANT SYNDROME 106 0.0089
78 BANKRUPTCY 4 0.0089
79 DISSOCIATION 67 0.0087
80 BREAST DISCHARGE 15 0.0086
81 EXTRAPYRAMIDAL DISORDER 212 0.0085
82 GESTATIONAL HYPERTENSION 11 0.0085
83 DERMATILLOMANIA 5 0.0084
84 OROMANDIBULAR DYSTONIA 6 0.0082
85 DROOLING 55 0.0080
86 SEDATION 207 0.0079
87 OBSESSIVE THOUGHTS 14 0.0078
88 FEELINGS OF WORTHLESSNESS 10 0.0077
89 WEIGHT INCREASED 1712 0.0076
90 THEFT 5 0.0075
91 TACHYPHRENIA 26 0.0075
92 STEREOTYPY 7 0.0074
93 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 10 0.0074
94 SELF-INJURIOUS IDEATION 31 0.0074
95 SEBORRHOEIC DERMATITIS 12 0.0073
96 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 44 0.0072
97 ELECTROCARDIOGRAM QT PROLONGED 252 0.0070
98 DELUSION 107 0.0069
99 DYSPHEMIA 30 0.0068
100 HYPERPROLACTINAEMIA 44 0.0068
101 LOSS OF EMPLOYMENT 20 0.0066
102 OBSESSIVE-COMPULSIVE DISORDER 53 0.0066
103 HEAD TITUBATION 9 0.0065
104 LOGORRHOEA 23 0.0065
105 ANOSOGNOSIA 5 0.0065
106 SUICIDAL IDEATION 595 0.0065
107 NEGATIVE THOUGHTS 19 0.0065
108 DYSTONIA 125 0.0064
109 TIC 35 0.0064
110 LIBIDO INCREASED 13 0.0064
111 ALCOHOL ABUSE 17 0.0064
112 CUTANEOUS T-CELL LYMPHOMA 8 0.0063
113 DYSKINESIA 243 0.0060
114 INCREASED APPETITE 114 0.0060
115 ANORGASMIA 16 0.0059
116 LAZINESS 10 0.0059
117 EYE MOVEMENT DISORDER 40 0.0058
118 GALACTORRHOEA 37 0.0058
119 PRODUCT USE IN UNAPPROVED INDICATION 1400 0.0056
120 SOMATIC SYMPTOM DISORDER 6 0.0056
121 NUCHAL RIGIDITY 5 0.0055
122 THERAPY CESSATION 283 0.0055
123 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 161 0.0055
124 DEMENTIA WITH LEWY BODIES 6 0.0054
125 SLEEP-RELATED EATING DISORDER 5 0.0053
126 APATHY 77 0.0053
127 PARANOIA 91 0.0053
128 METABOLIC SURGERY 6 0.0053
129 HUNGER 73 0.0052
130 PSYCHOTIC DISORDER 152 0.0051
131 STARING 12 0.0050
132 PERSONALITY DISORDER 13 0.0050
133 BRADYKINESIA 29 0.0049
134 MUSCLE TWITCHING 113 0.0049
135 AKINESIA 10 0.0048
136 LIP DISORDER 9 0.0047
137 DECREASED INTEREST 28 0.0047
138 PSYCHIATRIC SYMPTOM 35 0.0047
139 PRODUCT ADMINISTRATION INTERRUPTED 37 0.0047
140 PNEUMONIA ASPIRATION 117 0.0047
141 ANGER 156 0.0046
142 IMPRISONMENT 8 0.0045
143 HALLUCINATIONS, MIXED 19 0.0045
144 INAPPROPRIATE AFFECT 7 0.0044
145 SINUS NODE DYSFUNCTION 8 0.0044
146 THINKING ABNORMAL 81 0.0043
147 RESTLESS LEGS SYNDROME 79 0.0043
148 DISTRACTIBILITY 5 0.0043
149 SUICIDE ATTEMPT 260 0.0043
150 MENOPAUSE 11 0.0043
151 DEPRESSIVE SYMPTOM 15 0.0043
152 SEROTONIN SYNDROME 81 0.0042
153 MUSCLE RIGIDITY 50 0.0042
154 AGITATION 307 0.0042
155 SOMNAMBULISM 27 0.0041
156 MAJOR DEPRESSION 30 0.0041
157 SALIVARY HYPERSECRETION 41 0.0041
158 SLEEP PARALYSIS 6 0.0041
159 GENERALISED ANXIETY DISORDER 6 0.0041
160 TEMPERATURE REGULATION DISORDER 9 0.0040
161 SYMPTOM RECURRENCE 24 0.0040
162 MENTAL FATIGUE 6 0.0040
163 TREMOR 662 0.0040
164 TERMINAL INSOMNIA 7 0.0040
165 HOMICIDAL IDEATION 16 0.0039
166 DAYDREAMING 6 0.0039
167 IMPULSE-CONTROL DISORDER 8 0.0039
168 TRISMUS 20 0.0039
169 PANIC DISORDER 15 0.0039
170 BIPOLAR DISORDER 42 0.0039
171 IMPAIRED SELF-CARE 8 0.0039
172 POLYDIPSIA 15 0.0038
173 METABOLIC DISORDER 22 0.0038
174 PITUITARY TUMOUR BENIGN 6 0.0037
175 BLEPHAROSPASM 23 0.0036
176 CRANIOCEREBRAL INJURY 11 0.0036
177 POST-TRAUMATIC STRESS DISORDER 24 0.0036
178 ENERGY INCREASED 21 0.0036
179 ANTIPSYCHOTIC DRUG LEVEL INCREASED 10 0.0035
180 HOSTILITY 9 0.0035
181 MILIARIA 6 0.0035
182 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
183 DRUG LEVEL BELOW THERAPEUTIC 19 0.0034
184 CRYING 125 0.0034
185 CATATONIA 18 0.0034
186 TROPONIN INCREASED 26 0.0034
187 PSYCHOMOTOR HYPERACTIVITY 56 0.0034
188 DRUG MONITORING PROCEDURE NOT PERFORMED 6 0.0033
189 METABOLIC ENCEPHALOPATHY 10 0.0033
190 ELECTROCARDIOGRAM ABNORMAL 26 0.0033
191 AFFECTIVE DISORDER 26 0.0033
192 SCREAMING 21 0.0033
193 HALLUCINATION, VISUAL 69 0.0033
194 BODY TEMPERATURE ABNORMAL 6 0.0033
195 GASTROSTOMY 5 0.0032
196 HALLUCINATION 243 0.0032
197 ENURESIS 13 0.0032
198 FEELING OF DESPAIR 15 0.0032
199 SUBSTANCE USE 5 0.0032
200 UNDERDOSE 232 0.0032
201 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
202 DISINHIBITION 5 0.0031
203 SEXUAL DYSFUNCTION 36 0.0031
204 TREATMENT NONCOMPLIANCE 166 0.0030
205 TEARFULNESS 13 0.0030
206 PRODUCT PRESCRIBING ERROR 71 0.0030
207 IMMOBILE 13 0.0030
208 ENTEROBACTER INFECTION 5 0.0030
209 BODY MASS INDEX INCREASED 4 0.0030
210 IRRITABILITY 177 0.0029
211 ASPHYXIA 24 0.0029
212 AGORAPHOBIA 4 0.0029
213 WEIGHT ABNORMAL 7 0.0029
214 TONGUE BITING 6 0.0029
215 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
216 INTESTINAL ISCHAEMIA 16 0.0029
217 ABNORMAL BEHAVIOUR 115 0.0029
218 WRONG DOSE 7 0.0029
219 COMMUNICATION DISORDER 11 0.0029
220 PHYSICAL ASSAULT 6 0.0029
221 INTRACRANIAL PRESSURE INCREASED 16 0.0029
222 ELECTRIC SHOCK SENSATION 8 0.0029
223 AGGRESSION 143 0.0029
224 DRUG LEVEL DECREASED 29 0.0028
225 PSYCHOMOTOR RETARDATION 8 0.0028
226 SLEEP DEFICIT 6 0.0028
227 PANIC ATTACK 103 0.0028
228 STUPOR 9 0.0028
229 DEREALISATION 6 0.0028
230 LANGUAGE DISORDER 6 0.0028
231 SUSPECTED SUICIDE 13 0.0028
232 INTENTIONAL SELF-INJURY 56 0.0028
233 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
234 GASTRIC BYPASS 6 0.0028
235 PRODUCT USE ISSUE 516 0.0027
236 THIRST 49 0.0027
237 EUPHORIC MOOD 28 0.0027
238 PRE-EXISTING CONDITION IMPROVED 17 0.0027
239 FRUSTRATION TOLERANCE DECREASED 22 0.0027
240 APPETITE DISORDER 18 0.0027
241 OESOPHAGEAL SPASM 5 0.0027
242 INTERNAL HAEMORRHAGE 31 0.0027
243 APRAXIA 4 0.0027
244 EATING DISORDER 57 0.0027
245 IMPATIENCE 5 0.0027
246 DEPRESSED MOOD 140 0.0026
247 ORTHOSTATIC HYPOTENSION 46 0.0026
248 INITIAL INSOMNIA 27 0.0026
249 HYPERVOLAEMIA 13 0.0026
250 DEPRESSION 598 0.0026
251 ROSACEA 12 0.0026
252 ECONOMIC PROBLEM 39 0.0026
253 FEELING JITTERY 49 0.0026
254 NIGHTMARE 88 0.0025
255 DEMENTIA 71 0.0025
256 HYPERSOMNIA 71 0.0025
257 SLOW SPEECH 6 0.0025
258 TENSION 15 0.0025
259 POSTURE ABNORMAL 8 0.0025
260 WITHDRAWAL SYNDROME 103 0.0025
261 THERAPEUTIC RESPONSE UNEXPECTED 107 0.0024
262 SNORING 9 0.0024
263 MENTAL DISORDER 103 0.0024
264 ALCOHOLISM 10 0.0023
265 PHYSICAL DECONDITIONING 6 0.0023
266 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
267 GESTATIONAL DIABETES 11 0.0023
268 DRUG INTERACTION 363 0.0023
269 BIPOLAR I DISORDER 5 0.0023
270 THERAPY NON-RESPONDER 102 0.0023
271 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
272 PANIC REACTION 16 0.0022
273 MOVEMENT DISORDER 71 0.0022
274 ANXIETY 629 0.0022
275 POLYURIA 18 0.0022
276 SELF-MEDICATION 9 0.0022
277 DISTURBANCE IN ATTENTION 118 0.0022
278 MYOCARDITIS 25 0.0022
279 MENTAL IMPAIRMENT 52 0.0021
280 COGNITIVE DISORDER 100 0.0021
281 DISCOURAGEMENT 5 0.0021
282 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
283 BREAST ENLARGEMENT 7 0.0021
284 SOMNOLENCE 428 0.0021
285 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
286 LOSS OF LIBIDO 19 0.0021
287 IMPAIRED DRIVING ABILITY 24 0.0021
288 PRESCRIBED UNDERDOSE 42 0.0021
289 ADVERSE DRUG REACTION 189 0.0021
290 URINARY RETENTION 70 0.0021
291 HAEMATOLOGICAL INFECTION 5 0.0020
292 MUSCLE TIGHTNESS 33 0.0020
293 THERAPY CHANGE 20 0.0020
294 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
295 FEELING ABNORMAL 484 0.0020
296 DEVICE INFUSION ISSUE 5 0.0020
297 FORMICATION 14 0.0020
298 INCOHERENT 13 0.0020
299 RHABDOMYOLYSIS 83 0.0020
300 BRAIN FOG 31 0.0020
301 INSOMNIA 513 0.0019
302 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
303 ALCOHOL USE 7 0.0019
304 FEAR 51 0.0019
305 MUSCLE FATIGUE 8 0.0019
306 NYSTAGMUS 10 0.0019
307 CARDIAC DYSFUNCTION 7 0.0019
308 PRESCRIBED OVERDOSE 36 0.0019
309 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 89 0.0019
310 BRADYPHRENIA 12 0.0018
311 PRODUCT SUPPLY ISSUE 13 0.0018
312 DELIRIUM 63 0.0018
313 ADVERSE EVENT 167 0.0018
314 HYPERAMMONAEMIA 9 0.0018
315 POTENTIATING DRUG INTERACTION 6 0.0018
316 DISEASE RECURRENCE 85 0.0018
317 AFFECT LABILITY 17 0.0018
318 COMPLETED SUICIDE 147 0.0018
319 DRUG EFFECT INCOMPLETE 64 0.0018
320 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
321 DIZZINESS POSTURAL 17 0.0018
322 BRAIN OPERATION 4 0.0018
323 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
324 SLEEP APNOEA SYNDROME 33 0.0017
325 VITAMIN B12 DEFICIENCY 7 0.0017
326 COMA SCALE ABNORMAL 5 0.0017
327 MATERNAL EXPOSURE DURING BREAST FEEDING 7 0.0017
328 INCONTINENCE 18 0.0017
329 SOCIAL PROBLEM 7 0.0017
330 NERVOUSNESS 88 0.0017
331 POOR QUALITY SLEEP 36 0.0017
332 DECREASED ACTIVITY 18 0.0017
333 BEHAVIOUR DISORDER 9 0.0017
334 FACIAL PARALYSIS 14 0.0016
335 BREATH ODOUR 4 0.0016
336 DYSARTHRIA 61 0.0016
337 DIASTOLIC DYSFUNCTION 5 0.0016
338 DISABILITY 32 0.0016
339 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11 0.0016
340 HYPERACUSIS 6 0.0016
341 FLUID INTAKE REDUCED 8 0.0016
342 DYSPHAGIA 149 0.0016
343 MOUTH SWELLING 9 0.0016
344 PRODUCT COLOUR ISSUE 8 0.0016
345 ANAL INCONTINENCE 14 0.0016
346 ASPIRATION 17 0.0016
347 REHABILITATION THERAPY 6 0.0015
348 IMPAIRED GASTRIC EMPTYING 21 0.0015
349 MOOD ALTERED 42 0.0015
350 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
351 TONGUE DISORDER 11 0.0015
352 LISTLESS 5 0.0015
353 EXPOSURE VIA BREAST MILK 6 0.0015
354 HYSTERECTOMY 13 0.0015
355 MIDDLE INSOMNIA 28 0.0015
356 ANXIETY DISORDER 5 0.0015
357 COMPRESSION FRACTURE 8 0.0015
358 SPEECH DISORDER 78 0.0015
359 FEELING DRUNK 11 0.0015
360 SPINAL FUSION SURGERY 6 0.0015
361 PUSTULAR PSORIASIS 5 0.0015
362 IMPAIRED WORK ABILITY 31 0.0014
363 MUSCULOSKELETAL STIFFNESS 127 0.0014
364 ABNORMAL DREAMS 40 0.0014
365 INCORRECT DOSE ADMINISTERED 329 0.0014
366 HYPERREFLEXIA 5 0.0014
367 ERECTION INCREASED 6 0.0014
368 SLEEP TERROR 6 0.0014
369 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78 0.0014
370 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 101 0.0014
371 RESPIRATORY ARREST 39 0.0014
372 POLLAKIURIA 59 0.0014
373 DYSSTASIA 41 0.0014
374 DERMATITIS CONTACT 16 0.0014
375 NEUROLOGICAL SYMPTOM 8 0.0014
376 SLEEP DISORDER 98 0.0014
377 HYPOKINESIA 20 0.0014
378 SEIZURE 159 0.0014
379 FRACTURE 26 0.0014
380 LETHARGY 79 0.0014
381 ABORTION 4 0.0014
382 PRODUCT AVAILABILITY ISSUE 31 0.0014
383 OFF LABEL USE 1172 0.0013
384 EMOTIONAL DISORDER 41 0.0013
385 BREAST TENDERNESS 10 0.0013
386 IMPAIRED QUALITY OF LIFE 19 0.0013
387 MEMORY IMPAIRMENT 179 0.0013
388 DRUG PRESCRIBING ERROR 25 0.0013
389 PRODUCT DISTRIBUTION ISSUE 12 0.0013
390 CONDITION AGGRAVATED 388 0.0013
391 GLYCOSYLATED HAEMOGLOBIN INCREASED 32 0.0013
392 PRODUCT DOSE OMISSION 82 0.0013
393 ANHEDONIA 33 0.0013
394 MOOD SWINGS 40 0.0013
395 PRODUCT DISPENSING ERROR 27 0.0012
396 NOCTURIA 15 0.0012
397 INCORRECT DOSAGE ADMINISTERED 6 0.0012
398 CONFUSIONAL STATE 197 0.0012
399 CARDIOMYOPATHY 18 0.0012
400 SPINAL OPERATION 15 0.0012
401 BEDRIDDEN 16 0.0012
402 CEREBRAL DISORDER 9 0.0012
403 HOSPICE CARE 12 0.0012
404 DYSGRAPHIA 8 0.0012
405 ADVERSE REACTION 16 0.0012
406 INTENTIONAL OVERDOSE 77 0.0012
407 SINUS TACHYCARDIA 17 0.0012
408 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
409 FEEDING DISORDER 24 0.0012
410 URINARY INCONTINENCE 35 0.0012
411 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 239 0.0012
412 PRODUCT LABEL ISSUE 8 0.0012
413 BODY TEMPERATURE INCREASED 24 0.0012
414 UTERINE HAEMORRHAGE 5 0.0012
415 FALL 388 0.0012
416 TENSION HEADACHE 5 0.0012
417 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
418 CONCUSSION 9 0.0012
419 APHTHOUS ULCER 9 0.0012
420 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
421 ILEUS 14 0.0011
422 SWOLLEN TONGUE 35 0.0011
423 NO ADVERSE EVENT 203 0.0011
424 FOOD POISONING 6 0.0011
425 LIGAMENT SPRAIN 11 0.0011
426 BRAIN INJURY 11 0.0011
427 HICCUPS 9 0.0011
428 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
429 THERAPY PARTIAL RESPONDER 17 0.0011
430 PNEUMONIA BACTERIAL 10 0.0011
431 HYPERHIDROSIS 140 0.0011
432 EYE OPERATION 5 0.0011
433 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
434 PERSONALITY CHANGE 10 0.0011
435 ROAD TRAFFIC ACCIDENT 45 0.0011
436 TIBIA FRACTURE 5 0.0011
437 THERAPY INTERRUPTED 76 0.0011
438 PREMATURE LABOUR 6 0.0011
439 PRODUCT PACKAGING ISSUE 10 0.0011
440 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
441 NAIL DISORDER 9 0.0010
442 BODY TEMPERATURE DECREASED 10 0.0010
443 DRUG SCREEN POSITIVE 8 0.0010
444 CATARACT OPERATION 6 0.0010
445 FOOT OPERATION 5 0.0010
446 OBESITY 16 0.0010
447 DRUG TOLERANCE 5 0.0010
448 MIGRAINE 94 0.0010
449 SUBSTANCE ABUSE 8 0.0010
450 BLOOD GLUCOSE INCREASED 185 0.0010
451 HYPOPHAGIA 25 0.0010
452 MENISCUS INJURY 6 0.0010
453 BLOOD GLUCOSE ABNORMAL 18 0.0010
454 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
455 BLOOD CHOLESTEROL INCREASED 45 0.0010
456 MICTURITION URGENCY 11 0.0010
457 PRODUCT DOSE OMISSION ISSUE 283 0.0010
458 BALANCE DISORDER 83 0.0010
459 GAIT INABILITY 32 0.0010
460 WEIGHT FLUCTUATION 10 0.0010
461 DRUG INTOLERANCE 92 0.0010
462 PRODUCT USE COMPLAINT 15 0.0010
463 SENSATION OF FOREIGN BODY 8 0.0009
464 ERECTILE DYSFUNCTION 24 0.0009
465 PRODUCT RESIDUE PRESENT 5 0.0009
466 GAIT DISTURBANCE 177 0.0009
467 JAW DISORDER 5 0.0009
468 VISION BLURRED 125 0.0009
469 AUTISM SPECTRUM DISORDER 5 0.0009
470 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
471 PHOTOPHOBIA 17 0.0009
472 BLOOD SODIUM DECREASED 17 0.0009
473 HYPERTENSIVE CRISIS 10 0.0009
474 FOOT FRACTURE 17 0.0009
475 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
476 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 161 0.0009
477 DRY MOUTH 72 0.0009
478 TRICUSPID VALVE INCOMPETENCE 7 0.0009
479 LIP DRY 8 0.0009
480 DIABETES MELLITUS 67 0.0009
481 TEMPERATURE INTOLERANCE 9 0.0009
482 HYPERVENTILATION 5 0.0009
483 HEPATIC FUNCTION ABNORMAL 32 0.0009
484 CARDIO-RESPIRATORY ARREST 35 0.0008
485 AMNESIA 54 0.0008
486 SINUS BRADYCARDIA 8 0.0008
487 AUTOIMMUNE DISORDER 8 0.0008
488 VITAMIN D DECREASED 7 0.0008
489 SENSITIVE SKIN 6 0.0008
490 LIP SWELLING 27 0.0008
491 ARTHROPOD BITE 6 0.0008
492 MUSCLE STRAIN 7 0.0008
493 DIZZINESS 401 0.0008
494 OVERDOSE 173 0.0008
495 TACHYCARDIA 71 0.0008
496 RESPIRATORY DISTRESS 22 0.0008
497 PAROSMIA 6 0.0008
498 APHASIA 24 0.0008
499 INFUSION SITE SWELLING 5 0.0008
500 UNEVALUABLE EVENT 60 0.0008
501 HEAD DISCOMFORT 14 0.0008
502 HEAD INJURY 25 0.0008
503 PHOTOSENSITIVITY REACTION 13 0.0008
504 MATERNAL EXPOSURE DURING PREGNANCY 70 0.0008
505 MOTOR DYSFUNCTION 8 0.0008
506 HOSPITALISATION 120 0.0008
507 RIB FRACTURE 16 0.0008
508 LIMB INJURY 21 0.0008
509 SURGERY 45 0.0008
510 LOSS OF CONSCIOUSNESS 98 0.0008
511 PARAESTHESIA ORAL 11 0.0008
512 THERAPEUTIC PRODUCT EFFECT DECREASED 34 0.0008
513 PRODUCT FORMULATION ISSUE 5 0.0008
514 HEART RATE INCREASED 75 0.0008
515 CORONAVIRUS INFECTION 5 0.0008
516 SUDDEN DEATH 8 0.0008
517 EPILEPSY 23 0.0008
518 SENSORY DISTURBANCE 12 0.0007
519 DRUG INEFFECTIVE 984 0.0007
520 ANAL ABSCESS 4 0.0007
521 METASTASES TO LYMPH NODES 5 0.0007
522 BLOOD POTASSIUM INCREASED 12 0.0007
523 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
524 DECUBITUS ULCER 6 0.0007
525 PRODUCT PRESCRIBING ISSUE 16 0.0007
526 HYPOAESTHESIA ORAL 11 0.0007
527 RESPIRATION ABNORMAL 5 0.0007
528 JOINT STIFFNESS 19 0.0007
529 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
530 OEDEMA 39 0.0007
531 HYPERTRANSAMINASAEMIA 5 0.0007
532 FEELING HOT 44 0.0007
533 PHARYNGEAL SWELLING 7 0.0007
534 BLOOD PRESSURE INCREASED 109 0.0007
535 WEIGHT DECREASED 199 0.0007
536 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
537 DISORIENTATION 28 0.0007
538 SEASONAL ALLERGY 10 0.0007
539 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
540 DEATH 603 0.0007
541 MUSCLE SPASMS 128 0.0007
542 DRUG DOSE OMISSION 115 0.0007
543 HIATUS HERNIA 9 0.0007
544 DIPLOPIA 18 0.0007
545 BLOOD URIC ACID INCREASED 4 0.0007
546 EXPIRED PRODUCT ADMINISTERED 23 0.0007
547 PALPITATIONS 81 0.0007
548 HIP FRACTURE 22 0.0007
549 COLD SWEAT 12 0.0007
550 SOPOR 9 0.0007
551 POOR VENOUS ACCESS 7 0.0007
552 ATAXIA 8 0.0007
553 WRIST FRACTURE 8 0.0007
554 GASTROENTERITIS VIRAL 12 0.0007
555 FATIGUE 512 0.0007
556 ACCIDENTAL OVERDOSE 24 0.0007
557 HYPOAESTHESIA 98 0.0007
558 IRRITABLE BOWEL SYNDROME 14 0.0007
559 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
560 NIGHT SWEATS 21 0.0007
561 ENCEPHALOPATHY 16 0.0007
562 ANKLE FRACTURE 10 0.0006
563 APHONIA 9 0.0006
564 THERAPEUTIC RESPONSE DECREASED 39 0.0006
565 APNOEA 5 0.0006
566 VERTIGO 39 0.0006
567 HYPOGLYCAEMIA 31 0.0006
568 GASTROINTESTINAL INFLAMMATION 5 0.0006
569 INTESTINAL OBSTRUCTION 24 0.0006
570 PERIPHERAL SWELLING 98 0.0006
571 ANGIOEDEMA 28 0.0006
572 BLOOD PRESSURE DECREASED 42 0.0006
573 DRUG EFFECT DECREASED 34 0.0006
574 SWELLING FACE 41 0.0006
575 AMENORRHOEA 11 0.0006
576 MALNUTRITION 7 0.0006
577 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
578 MYDRIASIS 8 0.0006
579 STENT PLACEMENT 5 0.0006
580 CARDIAC FLUTTER 4 0.0006
581 RASH GENERALISED 16 0.0006
582 MUSCLE DISORDER 5 0.0006
583 ANGINA UNSTABLE 4 0.0006
584 VITAMIN D DEFICIENCY 6 0.0006
585 ABDOMINAL DISCOMFORT 103 0.0006
586 LIMB DISCOMFORT 19 0.0006
587 DISCOMFORT 37 0.0006
588 BLADDER DISORDER 6 0.0006
589 HYPOTONIA 6 0.0006
590 CARDIAC FAILURE ACUTE 4 0.0006
591 HEADACHE 376 0.0006
592 CARDIAC FAILURE 48 0.0006
593 QUALITY OF LIFE DECREASED 8 0.0006
594 CONSTIPATION 130 0.0006
595 INFUSION SITE ERYTHEMA 5 0.0006
596 THROAT TIGHTNESS 16 0.0006
597 NEPHROLITHIASIS 27 0.0006
598 SLUGGISHNESS 6 0.0006
599 TINNITUS 27 0.0006
600 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
601 PRODUCT CONTAINER ISSUE 5 0.0006
602 DYSPHONIA 34 0.0006
603 UNRESPONSIVE TO STIMULI 15 0.0006
604 PSYCHOLOGICAL TRAUMA 5 0.0006
605 MALAISE 254 0.0006
606 EJECTION FRACTION DECREASED 9 0.0006
607 PYELONEPHRITIS 5 0.0006
608 PRESYNCOPE 14 0.0006
609 ILLNESS 59 0.0006
610 LOWER LIMB FRACTURE 11 0.0006
611 LIVER INJURY 14 0.0006
612 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
613 URINARY TRACT INFECTION 97 0.0006
614 GRIP STRENGTH DECREASED 5 0.0006
615 RENAL PAIN 6 0.0006
616 MENSTRUATION IRREGULAR 15 0.0006
617 SYNCOPE 56 0.0006
618 LIVER FUNCTION TEST INCREASED 12 0.0006
619 SUBDURAL HAEMATOMA 8 0.0006
620 PARALYSIS 8 0.0006
621 DEHYDRATION 74 0.0006
622 BLOOD PRESSURE ABNORMAL 11 0.0006
623 SKIN LACERATION 6 0.0006
624 BACK INJURY 6 0.0006
625 FLUID RETENTION 28 0.0005
626 GYNAECOMASTIA 17 0.0005
627 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
628 SINUSITIS 56 0.0005
629 RASH 237 0.0005
630 DYSURIA 20 0.0005
631 BLINDNESS TRANSIENT 4 0.0005
632 DENTAL CARIES 6 0.0005
633 NERVE COMPRESSION 5 0.0005
634 IRON DEFICIENCY ANAEMIA 5 0.0005
635 HYPOKALAEMIA 25 0.0005
636 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
637 TOOTH DISORDER 12 0.0005
638 MUSCULAR WEAKNESS 61 0.0005
639 APPENDICITIS 5 0.0005
640 OCULAR DISCOMFORT 6 0.0005
641 NAUSEA 422 0.0005
642 HOT FLUSH 40 0.0005
643 MITRAL VALVE INCOMPETENCE 6 0.0005
644 INTENTIONAL DOSE OMISSION 15 0.0005
645 SCAB 6 0.0005
646 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
647 MYALGIA 89 0.0005
648 ELECTROLYTE IMBALANCE 6 0.0005
649 URTICARIA 86 0.0005
650 CHOKING 10 0.0005
651 VIRAL INFECTION 17 0.0005
652 VOMITING 240 0.0005
653 HYPERSENSITIVITY 94 0.0005
654 DRUG RESISTANCE 13 0.0005
655 BLOOD IRON DECREASED 6 0.0005
656 SINUS DISORDER 10 0.0005
657 MYOCLONUS 6 0.0005
658 ACCIDENT 6 0.0005
659 COORDINATION ABNORMAL 7 0.0005
660 SCIATICA 8 0.0005
661 OEDEMA PERIPHERAL 61 0.0005
662 DECREASED APPETITE 116 0.0005
663 CARDIAC ARREST 41 0.0005
664 PRODUCT PHYSICAL ISSUE 10 0.0005
665 PRODUCT ADMINISTRATION ERROR 10 0.0005
666 C-REACTIVE PROTEIN INCREASED 18 0.0005
667 ASTHENIA 186 0.0005
668 PAIN IN JAW 14 0.0005
669 EYELID PTOSIS 5 0.0005
670 DRY THROAT 5 0.0005
671 CEREBRAL INFARCTION 12 0.0005
672 PARAESTHESIA 77 0.0005
673 EAR DISCOMFORT 5 0.0005
674 BRONCHITIS 36 0.0005
675 COVID-19 85 0.0005
676 VENTRICULAR EXTRASYSTOLES 5 0.0005
677 NERVOUS SYSTEM DISORDER 15 0.0005
678 TOXICITY TO VARIOUS AGENTS 81 0.0005
679 HYPONATRAEMIA 27 0.0005
680 PETECHIAE 5 0.0005
681 HYPOTENSION 96 0.0005
682 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
683 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
684 LIVER DISORDER 21 0.0005
685 HYPOTHYROIDISM 15 0.0005
686 ALOPECIA 92 0.0005
687 HYPERGLYCAEMIA 17 0.0005
688 BLOOD POTASSIUM DECREASED 14 0.0005
689 CARDIAC OPERATION 4 0.0005
690 PHARYNGITIS STREPTOCOCCAL 5 0.0005
691 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
692 KIDNEY INFECTION 9 0.0005
693 DRUG DISPENSING ERROR 7 0.0005
694 BLOOD GLUCOSE FLUCTUATION 5 0.0005
695 EMOTIONAL DISTRESS 55 0.0005
696 FIBROMYALGIA 11 0.0005
697 UPPER LIMB FRACTURE 9 0.0005
698 DRUG ERUPTION 8 0.0005
699 CHEST DISCOMFORT 46 0.0004
700 CHEST PAIN 83 0.0004
701 SKIN INFECTION 5 0.0004
702 FREQUENT BOWEL MOVEMENTS 12 0.0004
703 PRODUCT TASTE ABNORMAL 6 0.0004
704 EYE INFECTION 5 0.0004
705 TOOTHACHE 8 0.0004
706 ABDOMINAL DISTENSION 46 0.0004
707 MYOCARDIAL ISCHAEMIA 5 0.0004
708 CONTUSION 42 0.0004
709 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
710 BRADYCARDIA 23 0.0004
711 METASTASES TO LUNG 5 0.0004
712 MENTAL STATUS CHANGES 12 0.0004
713 MADAROSIS 5 0.0004
714 HYPERTENSION 91 0.0004
715 RENAL IMPAIRMENT 36 0.0004
716 EYE DISORDER 14 0.0004
717 CEREBROVASCULAR ACCIDENT 72 0.0004
718 STAPHYLOCOCCAL INFECTION 14 0.0004
719 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
720 ABDOMINAL PAIN UPPER 87 0.0004
721 ARRHYTHMIA 20 0.0004
722 JOINT INJURY 9 0.0004
723 MUSCULOSKELETAL PAIN 22 0.0004
724 HYPERLIPIDAEMIA 5 0.0004
725 PAIN IN EXTREMITY 123 0.0004
726 DYSPEPSIA 41 0.0004
727 POST PROCEDURAL COMPLICATION 8 0.0004
728 TYPE 2 DIABETES MELLITUS 14 0.0004
729 GLAUCOMA 8 0.0004
730 FACE OEDEMA 7 0.0004
731 CANDIDA INFECTION 7 0.0004
732 HERNIA 8 0.0004
733 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
734 VISUAL IMPAIRMENT 51 0.0004
735 HEPATIC ENZYME INCREASED 28 0.0004
736 RESPIRATORY DEPRESSION 5 0.0004
737 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
738 PALLOR 11 0.0004
739 EYE SWELLING 15 0.0004
740 EXPOSURE DURING PREGNANCY 25 0.0004
741 GLOSSODYNIA 9 0.0004
742 ORAL PAIN 9 0.0004
743 SKIN LESION 11 0.0004
744 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
745 ABORTION SPONTANEOUS 16 0.0004
746 SPINAL FRACTURE 8 0.0004
747 SECRETION DISCHARGE 5 0.0004
748 HEART RATE IRREGULAR 9 0.0004
749 METASTASES TO LIVER 7 0.0004
750 DIVERTICULITIS 11 0.0004
751 TASTE DISORDER 8 0.0004
752 HIP ARTHROPLASTY 6 0.0004
753 OXYGEN SATURATION DECREASED 22 0.0004
754 NASAL CONGESTION 23 0.0004
755 PHARYNGEAL OEDEMA 6 0.0004
756 ROTATOR CUFF SYNDROME 5 0.0004
757 OSTEOPOROSIS 16 0.0004
758 LYMPHOMA 6 0.0004
759 INFUSION SITE PAIN 5 0.0004
760 FEMUR FRACTURE 12 0.0004
761 RASH PRURITIC 21 0.0004
762 PNEUMONIA 125 0.0004
763 DIARRHOEA 247 0.0004
764 DRUG-INDUCED LIVER INJURY 12 0.0004
765 GASTROINTESTINAL DISORDER 34 0.0004
766 TOOTH INFECTION 5 0.0004
767 PULMONARY EMBOLISM 36 0.0004
768 ARTHROPATHY 21 0.0004
769 OSTEOARTHRITIS 16 0.0004
770 CONJUNCTIVITIS 7 0.0004
771 AGRANULOCYTOSIS 7 0.0004
772 HEPATIC STEATOSIS 7 0.0004
773 EAR INFECTION 10 0.0004
774 RETCHING 8 0.0004
775 BREAST PAIN 4 0.0004
776 HEPATIC CIRRHOSIS 7 0.0004
777 RHINORRHOEA 24 0.0004
778 FLATULENCE 21 0.0004
779 SINUS CONGESTION 5 0.0004
780 PRURITUS GENERALISED 8 0.0004
781 DEEP VEIN THROMBOSIS 24 0.0004
782 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
783 OROPHARYNGEAL PAIN 34 0.0004
784 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
785 CEREBRAL HAEMORRHAGE 13 0.0004
786 ILL-DEFINED DISORDER 22 0.0004
787 DERMATITIS ATOPIC 19 0.0004
788 EAR PAIN 7 0.0004
789 FUNGAL INFECTION 12 0.0004
790 LEUKOPENIA 18 0.0004
791 ORAL DISCOMFORT 5 0.0004
792 TRANSAMINASES INCREASED 8 0.0004
793 FEELING COLD 10 0.0004
794 BLISTER 20 0.0004
795 EYE PAIN 20 0.0004
796 HEMIPARESIS 6 0.0004
797 BLOOD GLUCOSE DECREASED 17 0.0004
798 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
799 INFLUENZA LIKE ILLNESS 29 0.0004
800 CHOLECYSTECTOMY 4 0.0003
801 CHILLS 41 0.0003
802 RECTAL HAEMORRHAGE 15 0.0003
803 RESPIRATORY TRACT INFECTION 9 0.0003
804 CYSTITIS 11 0.0003
805 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
806 CHRONIC KIDNEY DISEASE 26 0.0003
807 PYREXIA 118 0.0003
808 HYPOXIA 12 0.0003
809 INFLUENZA 38 0.0003
810 DRY EYE 17 0.0003
811 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
812 LYMPHADENOPATHY 12 0.0003
813 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
814 TOOTH LOSS 7 0.0003
815 PAIN 207 0.0003
816 GALLBLADDER DISORDER 6 0.0003
817 HAEMORRHAGE INTRACRANIAL 5 0.0003
818 MOUTH ULCERATION 7 0.0003
819 LACRIMATION INCREASED 10 0.0003
820 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
821 SKIN DISORDER 11 0.0003
822 PRURITUS 126 0.0003
823 HYPOACUSIS 14 0.0003
824 DYSPNOEA 184 0.0003
825 BACK PAIN 75 0.0003
826 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
827 BACTERIAL INFECTION 6 0.0003
828 EXTRA DOSE ADMINISTERED 13 0.0003
829 INTENTIONAL PRODUCT MISUSE 28 0.0003
830 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
831 SEPSIS 35 0.0003
832 RASH ERYTHEMATOUS 15 0.0003
833 HEART RATE DECREASED 11 0.0003
834 ARTHRALGIA 130 0.0003
835 DRUG ABUSE 26 0.0003
836 ORAL HERPES 6 0.0003
837 MOBILITY DECREASED 22 0.0003
838 SKIN DISCOLOURATION 14 0.0003
839 NECK PAIN 17 0.0003
840 GASTRITIS 8 0.0003
841 ANKYLOSING SPONDYLITIS 4 0.0003
842 PERICARDIAL EFFUSION 7 0.0003
843 TREATMENT FAILURE 25 0.0003
844 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
845 CARDIAC DISORDER 28 0.0003
846 SWELLING 28 0.0003
847 INJURY 21 0.0003
848 NASOPHARYNGITIS 55 0.0003
849 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
850 FLUSHING 30 0.0003
851 NEUTROPHIL COUNT DECREASED 12 0.0003
852 BLOOD PRESSURE FLUCTUATION 7 0.0003
853 MUSCULOSKELETAL DISCOMFORT 5 0.0003
854 HAEMATOCHEZIA 16 0.0003
855 NEURALGIA 7 0.0003
856 ACUTE KIDNEY INJURY 44 0.0003
857 PANCYTOPENIA 16 0.0003
858 KNEE ARTHROPLASTY 6 0.0003
859 NEOPLASM MALIGNANT 19 0.0003
860 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
861 FAECES DISCOLOURED 6 0.0003
862 LEUKOCYTOSIS 5 0.0003
863 CARDIOVASCULAR DISORDER 7 0.0003
864 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
865 NEUROPATHY PERIPHERAL 26 0.0003
866 COMA 13 0.0003
867 MULTIPLE SCLEROSIS 13 0.0003
868 ANAPHYLACTIC REACTION 15 0.0003
869 RENAL FAILURE 36 0.0003
870 STEVENS-JOHNSON SYNDROME 6 0.0003
871 PSORIASIS 35 0.0003
872 ECZEMA 14 0.0003
873 SNEEZING 6 0.0003
874 THROAT IRRITATION 12 0.0003
875 BONE LOSS 4 0.0003
876 JOINT SWELLING 32 0.0003
877 GASTRIC DISORDER 9 0.0003
878 CARDIAC FAILURE CONGESTIVE 21 0.0003
879 INJECTION SITE RASH 8 0.0003
880 ACUTE RESPIRATORY FAILURE 5 0.0003
881 RENAL DISORDER 12 0.0003
882 SKIN FISSURES 5 0.0003
883 EPISTAXIS 19 0.0003
884 SEPTIC SHOCK 11 0.0003
885 HAEMATOCRIT DECREASED 5 0.0003
886 PRODUCTIVE COUGH 12 0.0003
887 ABSCESS 4 0.0003
888 THROMBOSIS 20 0.0002
889 LOCALISED INFECTION 6 0.0002
890 PANCREATITIS 13 0.0002
891 PRODUCT PREPARATION ERROR 5 0.0002
892 BURNING SENSATION 17 0.0002
893 VISUAL ACUITY REDUCED 8 0.0002
894 LIVER FUNCTION TEST ABNORMAL 7 0.0002
895 AGEUSIA 6 0.0002
896 NEEDLE ISSUE 7 0.0002
897 ABDOMINAL PAIN LOWER 6 0.0002
898 PRODUCT COMPLAINT 6 0.0002
899 HAEMATEMESIS 6 0.0002
900 COUGH 65 0.0002
901 NEUTROPENIA 31 0.0002
902 ABDOMINAL PAIN 53 0.0002
903 INTERSTITIAL LUNG DISEASE 11 0.0002
904 EYE IRRITATION 13 0.0002
905 RASH MACULO-PAPULAR 5 0.0002
906 ERYTHEMA 46 0.0002
907 PANCREATITIS ACUTE 5 0.0002
908 ASTHMA 25 0.0002
909 INFECTION 32 0.0002
910 CATARACT 13 0.0002
911 MYOCARDIAL INFARCTION 38 0.0002
912 PROCEDURAL PAIN 6 0.0002
913 ARTHRITIS 17 0.0002
914 CHOLELITHIASIS 7 0.0002
915 BLOOD URINE PRESENT 4 0.0002
916 EYE PRURITUS 7 0.0002
917 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
918 RESPIRATORY FAILURE 15 0.0002
919 DRUG DEPENDENCE 33 0.0002
920 INJECTION SITE URTICARIA 5 0.0002
921 ABASIA 5 0.0002
922 DYSGEUSIA 15 0.0002
923 COLITIS ULCERATIVE 9 0.0002
924 RESPIRATORY DISORDER 6 0.0002
925 CELLULITIS 10 0.0002
926 LUNG NEOPLASM MALIGNANT 8 0.0002
927 ANAPHYLACTIC SHOCK 5 0.0002
928 INFLAMMATION 10 0.0002
929 EXPOSURE VIA SKIN CONTACT 5 0.0002
930 DEAFNESS 5 0.0002
931 METABOLIC ACIDOSIS 6 0.0002
932 JAUNDICE 5 0.0002
933 PAIN OF SKIN 5 0.0002
934 ATRIAL FIBRILLATION 18 0.0002
935 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
936 BLOOD CREATININE INCREASED 12 0.0002
937 LUNG DISORDER 9 0.0002
938 IMPAIRED HEALING 6 0.0002
939 STOMATITIS 11 0.0002
940 MEDICATION ERROR 10 0.0002
941 CHROMATURIA 4 0.0002
942 HAEMATURIA 6 0.0002
943 HYPERKALAEMIA 6 0.0002
944 ACUTE MYOCARDIAL INFARCTION 5 0.0002
945 RENAL INJURY 5 0.0002
946 INFUSION RELATED REACTION 11 0.0002
947 SKIN EXFOLIATION 14 0.0002
948 PLEURAL EFFUSION 10 0.0002
949 ANAEMIA 31 0.0002
950 VAGINAL HAEMORRHAGE 7 0.0002
951 DEVICE DISLOCATION 7 0.0002
952 COLITIS 6 0.0002
953 ACNE 12 0.0002
954 HERPES ZOSTER 9 0.0002
955 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
956 BONE PAIN 9 0.0002
957 DRY SKIN 20 0.0001
958 BLOOD BILIRUBIN INCREASED 4 0.0001
959 PSORIATIC ARTHROPATHY 6 0.0001
960 OCULAR HYPERAEMIA 7 0.0001
961 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
962 PRODUCT ADHESION ISSUE 5 0.0001
963 SKIN BURNING SENSATION 10 0.0001
964 INJECTION SITE HAEMORRHAGE 11 0.0001
965 DRUG WITHDRAWAL SYNDROME 12 0.0001
966 INJECTION SITE MASS 5 0.0001
967 RHEUMATOID ARTHRITIS 15 0.0001
968 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
969 DEPENDENCE 7 0.0001
970 PLATELET COUNT DECREASED 13 0.0001
971 PRODUCT SUBSTITUTION ISSUE 7 0.0001
972 DEVICE MALFUNCTION 8 0.0001
973 INJECTION SITE BRUISING 9 0.0001
974 PULMONARY OEDEMA 5 0.0001
975 DEVICE EXPULSION 7 0.0001
976 INJECTION SITE PAIN 33 0.0001
977 THROMBOCYTOPENIA 12 0.0001
978 INJECTION SITE ERYTHEMA 13 0.0001
979 INJECTION SITE SWELLING 8 0.0001
980 PRODUCT STORAGE ERROR 9 0.0001
981 WHEEZING 6 0.0001
982 BLINDNESS 4 0.0001
983 BREAST CANCER 9 0.0001
984 HAEMORRHAGE 10 0.0001
985 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
986 HAEMOGLOBIN DECREASED 8 0.0001
987 DISEASE PROGRESSION 9 0.0001
988 INJECTION SITE PRURITUS 5 0.0001
989 PRODUCT QUALITY ISSUE 10 0.0001
990 DEVICE ISSUE 5 0.0001